NCT07041385Not yet recruiting
Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women
Source: ClinicalTrials.gov · Last updated 8 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate the effectiveness of 75 mg aspirin versus 150 mg aspirin in preventing preeclampsia among individuals with high risk for the condition. Existing literature suggests that the 150 mg aspirin dose may exhibit superior efficacy, yet inconclusive evidence exists in our local setting.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 340 (estimated)
- First submitted
- 19 Jun 2025
- Start date
- 1 Nov 2025
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Shalamar Hospital
- NCT number
- NCT07041385
What you commit to
- Study type: Interventional
- Planned participants: 340
- From 1 Nov 2025 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \> 30 y
- Gestational Age \> 14 weeks
Other
- Screen negative women
- Multiple Gestation
- Estimated risk for preterm PE of \< 1 in 100 (Reference - Fetal Medicine Foundation)
Who the study is looking for
- Screen positive women
- Age 18 - 30 y
- Gestational Age 11 - 13+6 weeks
- Singleton Pregnancy
- Estimated risk for preterm PE of \> 1 in 100 (Reference - Fetal Medicine Foundation)
Age in the registry: 18 years to 30 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shalamar Hospital Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.